FDA Reintroduces Leucovorin as a Potential Autism Treatment
TL;DR Summary
The FDA has reapproved GSK's leucovorin, a drug previously discontinued over 25 years ago, as part of a broader initiative by the Trump administration to explore potential autism treatments, with RFK Jr. promoting its use for autism.
- FDA brings back GSK’s leucovorin drug that RFK Jr. touted as autism treatment statnews.com
- F.D.A. to Relabel Leucovorin for Autism Treatment The New York Times
- The drug Trump plans to promote for autism shows real (and fragile) hope The Washington Post
- What is leucovorin? Researchers mixed on Trump, RFK Jr.'s potential answer to autism USA Today
- RFK Jr. Announces FDA Will Approve Leucovorin, a New Treatment for Autism. What Is It? People.com
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
1 min
vs 1 min read
Condensed
80%
183 → 37 words
Want the full story? Read the original article
Read on statnews.com